Declining incidence of cerebral palsy in South Korea: Linked analysis of the National Health Insurance database and the health screening data

doi:10.21203/rs.3.rs-2242203/v2

Download PDF

Article

Declining incidence of cerebral palsy in South Korea: Linked analysis of the National Health Insurance database and the health screening data

https://doi.org/10.21203/rs.3.rs-2242203/v2

This work is licensed under a CC BY 4.0 License

Journal Publication

published 28 Jun, 2023

Read the published version in Scientific Reports →

You are reading this latest preprint version

Background

Presuming that the prevalence of cerebral palsy (CP) in Korea is decreasing due to medical advances, we analyzed the trends and risk factors of CP in changing circumstances.

Methods

We identified all women who delivered a singleton between 2007 and 2015 using the Korea National Health Insurance (KNHI). Information on pregnancy and birth was obtained by linking the KNHI claims database and data from the national health-screening program for infants and children.

Results

Over 90% of children with CP were diagnosed within four years of birth. Moreover, the 4-year incidence of CP decreased significantly from 4.77 to 2.52 per 1000 babies during the study period. Multivariate analysis showed that the risk of developing CP was 3.9 times higher in babies with preterm birth, 5.6 times higher in those with birth weight <2500 g, and 4.1 times higher in pregnancies with polyhydramnios. Over time, the number of preterm births and babies with low birth weight decreased, while polyhydramnios became slightly more prevalent.

Conclusion

In Korea, the incidence of CP in singleton decreased from 2007 to 2015. In addition, the number of preterm births and babies with a low birth weight, which are major risk factors for CP, also declined.

Health sciences/Medical research

Health sciences/Neurology

Cerebral Palsy

Preterm Birth

Low Birth Weight

Polyhydramnios

Korea

Cerebral palsy (CP) is defined as a group of permanent disorders of the development of movement and posture causing activity limitation attributed to non-progressive disturbances in the developing fetal or infant brain.[1] In addition to physical disability, CP can be accompanied by cognitive impairment, communication problems, and epilepsy, which cause considerable personal and socioeconomic burdens. The medical community's ongoing efforts to reduce this burden have significantly improved healthcare technology over the past few decades. The early identification of women at risk of preterm birth and protective methods for reducing perinatal complications may decrease the incidence of preterm birth and fetal mortality.[2] Moreover, asphyxia is suspected, brain cooling has been widely used to protect the neonatal brain. Presuming that the prevalence of CP in Korea is decreasing due to medical advances, we attempted to analyze the latest trends and risk factors for CP in changing circumstances.

Healthcare delivery system in Korea

Almost all Koreans are covered by the health insurance policies of the Korea National Health Insurance (KNHI) of the Health Insurance Review and Assessment Service, except for 3% of the population that the Medical Aid Program covers. Thus, the KNHI claims database contains claims information for most Koreans except for uninsured procedures, such as plastic surgery. As a part of the National Health Insurance Corporation healthcare system, the national health-screening program for infants and children, for which children aged 4 to 80 months are eligible, began in 2007 and is composed of seven consecutive health examinations according to age (4–9, 9–18, 18–30, 30–42, 42–54, 54–66, and 66–80 months). The national health-screening program consists of history taking, physical examination, developmental screening, visual acuity, and a dental examination.

Study population

Information on pregnancy and birth was obtained by linking the KNHI claims database and national health screening program data for infants and children. Using the KNHI claims database, we identified all women who had delivered a baby between 2007 and 2015. A total of 3,778,561 women who had deliveries were identified. Excluding 56,925 deliveries of multiple births, a total of 3,278,916 single births were included in our study. Detailed information, such as medical illness, delivery mode, pregnancy complications, and single or multiple pregnancies, was confirmed using data from the KNHI claims and the national health-screening program for infants and children.

Definitions of CP

According to The International Classification of Diseases, Tenth Revision, CP was defined as a medical claim case with a CP diagnostic code. Included diagnostic codes were as follows: spastic quadriplegic CP (G80.0), spastic diplegic CP (G80.1), spastic hemiplegic CP (G80.2), dyskinetic CP (G80.3), ataxic CP (G80.4), other CP (G80.8), CP, unspecified (G80.9), flaccid hemiplegia (G81.0), spastic hemiplegia (G81.1), hemiplegia, unspecified (G81.9), flaccid paraplegia (G82.0), spastic paraplegia (G82.1), paraplegia, unspecified (G82.2), flaccid tetraplegia (G82.3), spastic tetraplegia (G82.4), tetraplegia, unspecified (G82.5), and paralytic syndromes (G83.0-83.3). Hereditary spastic paraplegia (G11.4) was excluded. The observational period was at least four years after birth, and upon diagnosis of CP, the number of people was summed based on the child's year of birth.

Statistical analysis

The Student's t-test was used to compare continuous variables between groups, and the categorical variables were compared using the χ² test. We compared temporal trends by using the χ² test. Multivariate logistic regression analysis was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (CI). All P-values were two-sided and were considered statistically significant if 0.050 or less. Statistical analysis was performed using SPSS software version 12.0 (SPSS Inc., Chicago, IL, USA)

This study was approved by the institutional review board of the Korea University Guro Hospital approved the study (2020GR0468). Informed consent of the patients was waived because of its retrospective nature. All methods were carried out in accordance with relevant guidelines and regulations.

Trends in vaginal and cesarean births by year

As shown in Fig. 1, the number of single vaginal births from 2007 to 2015 appeared to be modestly declining, while the number of cesarean deliveries increased slightly, though the changes were insignificant.

Incidence of cerebral palsy

It takes approximately four years after birth for most children to be diagnosed with CP; more than 70% of children were diagnosed within two years, more than 80% within three years, and more than 90% within four years (Fig. 2). As shown in Fig. 3, the incidence of CP decreased from 4.77 to 2.52 per 1000 single live births, from 6.23 to 3.37 among cesarean deliveries, and from 3.96 to 1.96 among vaginal births (P < 0.001 for vaginal births and total live births; P = 0.0012 for cesarean births).

Comparison of the study population

According to a combined analysis of maternal and their babies' records, the frequency of advanced maternal age, hypertension and diabetes before and during pregnancy, diabetes mellitus before pregnancy, cesarean delivery, gestational hypertension, gestational diabetes mellitus requiring insulin treatment, chorioamnionitis, premature rupture of membrane, oligo- and polyhydramnios, preterm birth, low birth weight, male sex, and large for gestational age was higher in the group diagnosed with CP than in the controls (Table 1).

Table 1

Comparison of study populations
	Control (n = 3,268,693)	Cerebral palsy (n = 10,223)	P-value
Maternal age (years)	30.88 (3.87)	31.00 (4.07)	0.002
Maternal age > 35 years	538,542 (16.48)	1,871 (18.30)	< 0.001
Hypertension	106,401 (3.26)	500 (4.89)	< 0.001
DM	156,421 (4.79)	647 (6.33)	< 0.001
Cesarean delivery	1,178,746 (36.06)	4,873 (47.67)	< 0.001
Gestational hypertension	62,801 (1.92)	643 (6.29)	< 0.001
GDM without insulin	276,871 (8.47)	834 (8.16)	0.258
GDM with insulin	25,193 (0.77)	165 (1.61)	< 0.001
Chorioamnionitis	23,195 (0.71)	266 (2.60)	< 0.001
Premature rupture of membrane	518,472 (15.86)	2,327 (22.76)	< 0.001
Oligohydramnios	34,660 (1.06)	356 (3.48)	< 0.001
Polyhydramnios	3,394 (0.10)	88 (0.86)	< 0.001
Preterm birth	82,468 (2.52)	2,862 (28.00)	< 0.001
34–36/6 weeks	57,472 (1.76)	631 (6.17)
28–33/6 weeks	22,400 (0.69)	1457 (14.25)
<28 weeks	2,596 (0.08)	774 (7.57)
Low birth weight (< 2500 g)	112,671 (3.45)	3,331 (32.58)	< 0.001
Male	1,683,526 (51.50)	5,984 (58.53)	< 0.001
Large for gestational age (≥ 4000 g)	124,443 (3.81)	255 (2.49)	< 0.001
Values are presented as mean (standard deviation) or n (%)
Abbreviations: DM, diabetes mellitus; GDM, gestational diabetes mellitus.

Risk factors for developing cerebral palsy

On multivariate analysis, maternal DM (OR = 1.16; 95% CI: 1.07–1.26), cesarean section (OR = 1.25; 95% CI: 1.20–1.31), chorioamnionitis (OR = 1.19; CI: 1.04–1.36), oligohydramnios (OR = 1.49; CI: 1.33–1.66), polyhydramnios (OR = 4.23 CI: 3.36–5.32), low birth weight (OR = 4.64; CI: 4.31–4.99), and male (OR = 1.34; 95% CI: 1.29–1.40) were associated with a higher risk of CP, but large for gestational age (OR = 0.87; 95% CI: 0.77–0.99) was associated with a lower risk of CP as shown in Table 2. Preterm birth was associated with an increase in the risk of CP, and in particular, the lower the gestational age at birth, the greater the risk of CP.

Table 2

Risk factors for developing cerebral palsy in singleton pregnancy
	Unadjusted OR (95% CI)	Adjusted OR (95% CI)
Maternal age > 35 years	1.14 (1.08, 1.19)	0.94 (0.89, 0.99)
HTN	1.53 (1.40, 1.67)	1.07 (0.98, 1.18)
DM	1.35 (1.24, 1.46)	1.16 (1.07, 1.26)
Cesarean delivery	1.62 (1.55, 1.68)	1.25 (1.20, 1.31)
Preeclampsia	3.43 (3.16, 3.71)	0.98 (0.89, 1.07)
GDM without insulin	0.96 (0.90, 1.03)	0.83 (0.77, 0.90)
GDM with insulin	2.12 (1.81, 2.47)	1.48 (1.24, 1.77)
Chorioamnionitis	3.74 (3.31, 4.23)	1.19 (1.04, 1.36)
Preterm rupture of membrane	1.56 (1.49, 1.64)	0.98 (0.93, 1.03)
Oligohydramnios	3.37 (3.03, 3.74)	1.49 (1.33, 1.66)
Polyhydramnios	8.37 (6.77, 10.35)	4.23 (3.36, 5.32)
Preterm birth
Term birth	1	1
34–36/6 weeks	4.75 (4.38–5.16)	1.78 (1.62–1.96)
28–33/6 weeks	28.16 (26.58–29.83)	6.38 (5.84–6.96)
<28 weeks	129.06 (118.72-140.29)	28.51 (25.58–31.80)
Low birth weight (< 2500 g)	13.54 (12.98, 14.12)	4.64 (4.31, 4.99)
Male	1.33 (1.28, 1.38)	1.34 (1.29, 1.40)
Large for gestational age (≥ 4000 g)	0.65 (0.57, 0.73)	0.87 (0.77, 0.99)
OR = odds ratio, CI = confidence interval.
Adjusted for variables in the table

Yearly occurrence of risk factors

The number of occurrences by year of the three major risk factors is shown in Fig. 4. The number of preterm and low-birth-weight babies decreased yearly, while the number of pregnancies with polyhydramnios increased slightly (P < 0.001).

Our data revealed that the incidence of CP per 1000 live births declined significantly from 4.77 to 2.52 babies among all live single births between 2007 and 2015. More than 90% of children with CP were diagnosed within four years of birth. The risk of developing CP was 5.6 times higher in babies weighing < 2500 g, 3.9 times higher in babies born preterm, and approximately 4.1 times higher in babies born from pregnancies with polyhydramnios.

The incidence rate of cerebral palsy

A previous study in South Korea found that the incidence of CP increased from 2.2 to 3.2 per 1000 children born between 1999 and 2003.[3] The incidence of CP in Korea decreased from 4.77 to 2.52 per 1000 babies between 2007 and 2015, close to the CP incidence in developed countries. According to a meta-analysis analyzing 19 previous reports using live births as the denominator, the overall prevalence of CP is 2.11 per 1000 births.[4] The included studies were from the USA, Canada, Australia, or Europe, except one study from China. Nationwide population studies in other Asian countries have recently reported a prevalence of CP of 1.09 per 1000 children under 20 years of age in Taiwan,[5] 1.19 in children aged 0–6 years in China,[6] and 2.26 in children aged 0–4 years in Japan.[7]

Risk factors for cerebral palsy

Medical advances may be a possible explanation for why the incidence of CP has decreased. Among them, early detection and prevention of preterm labor, magnesium sulfate treatment for preterm birth, and post-brain injury management, such as brain cooling, are at the forefront of medical progress. Our study showed that low birth weight (< 2500 g), preterm birth, and polyhydramnios are still major risk factors for developing CP in Korea.

1) Preterm birth

Aside from our study results, preterm birth is already well-known as a risk factor for CP.[8, 9] The immature brain cannot effectively maintain a blood supply because there are fewer collateral vessels or anastomoses around the peripheral blood vessels and immature walls. The vessels cannot compensate for hypoxic-ischemic damage to limited vasodilation capacity.[10] Thus, various attempts have been made to prevent preterm birth; 17α-hydroxyprogesterone caproate may help prevent recurrent preterm birth.[11–13] Furthermore, vaginal progesterone prevents premature birth of mothers with short cervixes and improves neonatal outcomes.[14–16] Overall, progesterone administration lowered the rate of preterm births by approximately 50%.[15, 17] Cervical pessary use or cervical cerclage prevents repeated preterm births in high-risk women with a short cervix.[18] Despite medical advances, the rate of preterm births increased from 2.9% (1997–1999) to 4.5% (2011–2013)[19] and from 3.31% (1997–1998) to 6.44% (2013–2014)[20] in Korea. The increase in twin births is thought to have contributed to the rise in preterm births. As shown in Fig. 4, singleton's incidence of preterm birth gradually decreased between 2007 and 2015 (P < 0.001) in our study.

2) Low birth weight

The association between the development of CP and fetal growth restriction is well known. This association is not related to the gestational age at delivery.[21] Fetal growth restriction has been reported as a more critical risk factor for CP than fetal inflammation and birth asphyxia combined.[22] Intrauterine infection, one of the major causes of intrauterine growth retardation, can cause fetal inflammatory response syndrome: fetal growth restriction, damage to blood vessels in the fetal brain, placental vascular disorders associated with congenital disabilities, and white matter damage. Among them, white matter damage is a typical pathologic hallmark of CP. Our study also showed that the risk of developing CP was 4.6 times higher in babies weighing less than 2500 g. Fortunately, between 2007 and 2015, the number of low birth weight babies decreased (Fig. 4, P < 0.001).

3) Polyhydramnios

Polyhydramnios was found to quadruple the risk of CP in our study. Polyhydramnios has also been associated with increased perinatal morbidity and mortality risk, such as preterm birth, aneuploidy, cesarean section, fetal anomalies, and perinatal and postnatal mortality.[23, 24] Even when the results of a detailed ultrasound examination of the fetus were normal, polyhydramnios doubled the risk of genetic syndromes, neurologic disorders, and fetal malformations diagnosed after birth.[25] The incidence of polyhydramnios slightly increased over the study period (Fig. 4, P < 0.001). Older maternal age could be one of the underlying reasons for this change. In addition, considering that efforts to reduce the occurrence of CP have focused on preventing perinatal asphyxia and preterm birth and developing treatments to minimize brain damage and not the prevention of polyhydramnios, it is considered a natural result.

4) Direct efforts to reduce the chances of neonatal brain injury

There have been various advances in medical technology that have minimized neonatal brain injury and mortality. First, magnesium sulfate (MgSO₄) stabilizes blood pressure, reduces vasoconstriction in the cerebral arteries, and restores circulation in preterm neonates.[26, 27] Treatment with MgSO₄ in preterm labor may lower the risk of CP.[28–30] The proportion of moderate to severe CP decreased significantly in babies born in women with preterm birth who were treated with magnesium (relative risk, 0.55; 95% CI 0.32–0.95)[29]; several meta-analyses also support this result.[31–33] Second, the prenatal administration of corticosteroids for fetal lung maturity may reduce the occurrence of CP.[34] Finally, brain or whole-body cooling has become standard management for neuroprotection in newborns with birth asphyxia.[35, 36]

With all these efforts, Korea's infant mortality rate decreased from 4.7 in 2004 to 3.0 in 2014.[37] Our study found that the incidence of CP also continues to decline in Korea.

Limitations

Our data do not include perinatal or postnatal neonatal risks, such as birth asphyxia, neonatal sepsis, or respiratory distress syndrome. We did not include early infantile risks, such as encephalitis or head trauma, which may also cause CP. A child can be diagnosed with CP when a precipitating event occurs before the affected function has developed.[1]

In Korea, the incidence of CP decreased from 2007 to 2015. In addition, the number of preterm and low-birth-weight births, a significant risk factor for CP, was also reduced.

cerebral palsy

KNHI

Korea National Health Insurance

odds ratio

confidence interval

Ethics approval and consent to participate

The institutional review board of the Korea University Guro Hospital approved the study and granted a waiver for informed consent because of its retrospective nature.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used or analyzed during the current study are available from the corresponding

author upon reasonable request.

Disclosure

The authors have no potential conflicts of interest to disclose.

Funding

This work was supported by a grant from the Korea Institute of Radiological and Medical

Sciences (KIRAMS), funded by the Ministry of Science and ICT (MSIT), Republic of

Korea (grant number 50543-2022).

Acknowledgments

Not applicable.

Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson BJDMCNS: A report: the definition and classification of cerebral palsy April 2006. 2007, 109(suppl 109):8–14.
Jung EJ, Byun JM, Kim YN, Lee KB, Sung MS, Kim KT, Shin JB, Jeong DHJTJoM-F, Medicine N: Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation. 2018, 31(11):1431–1441.
Park MS, Kim SJ, Chung CY, Kwon DG, Choi IH, Lee KMJHp: Prevalence and lifetime healthcare cost of cerebral palsy in South Korea. 2011, 100(2–3):234–238.
Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim TJDM, Neurology C: An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. 2013, 55(6):509–519.
Chiang K-L, Kuo F-C, Cheng C-Y, Chang K-PJCsNS: Prevalence and demographic characteristics of comorbid epilepsy in children and adolescents with cerebral palsy: a nationwide population-based study. 2019, 35(1):149–156.
He P, Chen G, Wang Z, Guo C, Zheng XJJop, health c: Children with motor impairment related to cerebral palsy: prevalence, severity and concurrent impairments in China. 2017, 53(5):480–484.
Toyokawa S, Maeda E, Kobayashi YJDM, Neurology C: Estimation of the number of children with cerebral palsy using nationwide health insurance claims data in Japan. 2017, 59(3):317–321.
Vincer MJ, Allen AC, Joseph K, Stinson DA, Scott H, Wood EJP: Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. 2006, 118(6):e1621-e1626.
Ancel P-Y, Livinec F, Larroque B, Marret S, Arnaud C, Pierrat V, Dehan M, Sylvie N, Escande B, Burguet AJP: Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. 2006, 117(3):828–835.
Bauer R, Zwiener U, Buchenau W, Bergmann R, Beyer R, Beyer G-J, Hoyer D, Lampe VJEp: Interaction between systemic circulation and brain injuries in newborns. 1991, 42(4):197–203.
Johnson JW, Austin KL, Jones GS, Davis GH, King TMJNEJoM: Efficacy of 17α-hydroxyprogesterone caproate in the prevention of premature labor. 1975, 293(14):675–680.
Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner B, Kessler I, Lancet MJAjoo, gynecology: Prevention of premature labor by 17α-hydroxyprogesterone caproate. 1985, 151(5):574–577.
Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MWJNEJoM: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. 2003, 348(24):2379–2385.
De Franco E, O'brien J, Adair C, Lewis D, Hall D, Fusey S, Soma-Pillay P, Porter K, How H, Schakis RJUiO et al: Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial. 2007, 30(5):697–705.
Hassan S, Romero R, Vidyadhari D, Fusey S, Baxter J, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey PJUiO et al: Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trial. 2011, 38(1):18–31.
da Fonseca EB, Bittar RE, Carvalho MH, Zugaib MJAjoo, gynecology: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. 2003, 188(2):419–424.
Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Klein K, Rode LJAjoo et al: Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and meta-analysis of individual patient data. 2012, 206(2):124. e121-124. e119.
Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A, Juan M, Rodríguez A, Muñoz B, Santacruz BJTL: Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. 2012, 379(9828):1800–1806.
Park SH, Lim DOJJKSMCH: Secular Trends of Gestational Length Distribution in Korean Singleton and Twin Birth: 1997 ~ 99, 2011 ~ 13. 2016, 20(1):66.
Park SH, Kim JS, Lim DOJJoHI, Statistics: Secular trend of gestational age specific preterm birth rate in Korean singleton and multiple birth: 1997-98, 2013-14. 2017, 42(1):10–15.
Croen LA, Grether JK, Curry CJ, Nelson KBJTJop: Congenital abnormalities among children with cerebral palsy: more evidence for prenatal antecedents. 2001, 138(6):804–810.
McIntyre S, Blair E, Badawi N, Keogh J, Nelson KBJO, Gynecology: Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. 2013, 122(4):869–877.
Pauer H-U, Viereck V, Krauss V, Osmers R, Krauss TJAog, obstetrics: Incidence of fetal malformations in pregnancies complicated by oligo-and polyhydramnios. 2003, 268(1):52–56.
Morris R, Meller C, Tamblyn J, Malin G, Riley R, Kilby M, Robson S, Khan KJBAIJoO, Gynaecology: Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. 2014, 121(6):686–699.
Yefet E, Daniel-Spiegel EJP: Outcomes from polyhydramnios with normal ultrasound. 2016, 137(2):e20151948.
de Haan HH, Gunn AJ, Williams CE, Heymann MA, Gluckman PDJAjoo, gynecology: Magnesium sulfate therapy during asphyxia in near-term fetal lambs does not compromise the fetus but does not reduce cerebral injury. 1997, 176(1):18–27.
Schiff SJ, Somjen GGJBr: Hyperexcitability following moderate hypoxia in hippocampal tissue slices. 1985, 337(2):337–340.
Nelson KB, Grether JKJO, Survey G: Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? 1995, 50(8):573–575.
Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JMJNEJoM: A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. 2008, 359(9):895–905.
Gibbins KJ, Browning KR, Lopes VV, Anderson BL, Rouse DJJO, Gynecology: Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention. 2013, 121(2 PART 1):235–240.
Conde-Agudelo A, Romero RJAjoo, gynecology: Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and meta-analysis. 2009, 200(6):595–609.
Costantine MM, Weiner SJJO, gynecology: Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. 2009, 114(2 Pt 1):354.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse DJCDoSR: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. 2009(1).
Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas GJO, Gynecology: Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. 2015, 125(6):1385–1396.
Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter EJNEJoM: Moderate hypothermia to treat perinatal asphyxial encephalopathy. 2009, 361(14):1349–1358.
Edwards A, Azzopardi DJAoDiC-F, Edition N: Therapeutic hypothermia following perinatal asphyxia. 2006, 91(2):F127-F131.
Shin H-Y, Lee J-Y, Song J, Lee S, Lee J, Lim B, Kim H, Huh S: Infant, maternal, and perinatal mortality statistics in the Republic of Korea, 2014. Journal of the Korean Medical Association 2017, 60(7):588–597.

No competing interests reported.

Download PDF

Journal Publication

published 28 Jun, 2023

Read the published version in Scientific Reports →

Editorial decision: Major revision
24 Feb, 2023
Reviews received at journal
24 Feb, 2023
Reviews received at journal
21 Jan, 2023
Reviewers agreed at journal
16 Jan, 2023
Reviewers invited by journal
10 Jan, 2023
Editor assigned by journal
02 Jan, 2023
Editor invited by journal
06 Dec, 2022
Submission checks completed at journal
06 Dec, 2022
First submitted to journal
01 Dec, 2022

You are reading this latest preprint version

Declining incidence of cerebral palsy in South Korea: Linked analysis of the National Health Insurance database and the health screening data

Status:

Journal Publication

Version 2

Abstract

Figures

Background

Methods

Healthcare delivery system in Korea

Study population

Definitions of CP

Statistical analysis

Results

Trends in vaginal and cesarean births by year

Incidence of cerebral palsy

Comparison of the study population

Risk factors for developing cerebral palsy

Yearly occurrence of risk factors

Discussion

The incidence rate of cerebral palsy

Risk factors for cerebral palsy

1) Preterm birth

2) Low birth weight

3) Polyhydramnios

4) Direct efforts to reduce the chances of neonatal brain injury

Limitations

Conclusion

Abbreviations

Declarations

References

Additional Declarations

Status:

Journal Publication

Version 2